Published Guidance, NICE advice and quality standards
Showing 1 to 4 of 4
Title | Reference number | Published | Last updated |
---|---|---|---|
Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over | TA986 | ||
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (terminated appraisal) | TA987 | ||
Selective internal radiation therapy with QuiremSpheres for treating unresectable advanced hepatocellular carcinoma | TA985 | ||
Selective internal radiation therapies for treating hepatocellular carcinoma | TA688 |